At a glance
ClinicalIndex Comparison RecordN/ACompleted· 221 enrolled
Drug / intervention
JUVÉDERM VOLUMA® XCdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Multicenter, Single-blind, Randomized, Controlled Study of the Safety and Effectiveness of JUVÉDERM VOLUMA® XC Injectable Gel for Chin Augmentation
In Brief
A clinical study evaluating JUVÉDERM VOLUMA® XC for Chin Retrusion. Completed, enrolled 221 participants across 14 sites.
Detailed Summary
This is a safety and effectiveness study of JUVÉDERM VOLUMA XC injectable gel for chin augmentation to correct volume deficit in chin retrusion.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsChin Retrusion
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
2017201820192020202120222023202420252026
Enrollment StartJun 2016
First PostedJul 2016
Primary CompletionFeb 2018
Study CompletionOct 2018
TodayJul 2026
First PostedJul 14, 2016
Enrollment StartJun 28, 2016
Primary CompletionFeb 6, 2018
Study CompletionOct 11, 2018
TodayJul 2, 2026
Enrollment to primary: 1.6 yearsPosted 10.0 years ago
Interventions
JUVÉDERM VOLUMA® XCdevice
JUVÉDERM VOLUMA® XC was injected into the chin at a volume determined by the investigator. The maximum total volume administered was up to 4 mL.